Global Electrophoresis Reagents Market, By Product (Gels, Dyes, Buffers, Others), Technique (Gel Electrophoresis, Capillary Electrophoresis), End-User (Research Institutions, Pharmaceutical and Biotechnology Companies, Hospitals and Clinics, Diagnostic Laboratories, Others) – Industry Trends and Forecast to 2029
Market Analysis and Size
Rising demand from the pharmaceutical and biotechnology industries, the electrophoresis reagents market is likely to increase revenue over the forecast period 2022 to 2029 significantly. Furthermore, the focus on research growth in developing countries is predicted to raise demand for electrophoresis reagents.
Data Bridge Market Research analyses that the electrophoresis reagents market which was USD 1.07 billion in 2021, would rocket up to USD 1.52 billion by 2029, and is expected to undergo a CAGR of 4.47% during the forecast period 2022 to 2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Market Definition
Electrophoresis is a technique of separating and differentiating DNA and RNA depending on their size and charge. The process is used to separate and sort macromolecules from a sample. This technique is widely employed for diagnostic and research purposes in a variety of pharmaceutical applications.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product (Gels, Dyes, Buffers, Others), Technique (Gel Electrophoresis, Capillary Electrophoresis), End-User (Research Institutions, Pharmaceutical and Biotechnology Companies, Hospitals and Clinics, Diagnostic Laboratories, Others)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
BioCT (U.S), Promega Corporation (U.S), EUROCLONE S.p.A. ( Italy), Helena Laboratories Corporation (U.S), Apacor Limited (U.S), Thermo Fisher Scientific Inc. (U.S.), Sigma-Aldrich Corporation (U.S), Bio-Rad Laboratories, Inc. (U.S), Lonza (Switzerland), QIAGEN (Netherlands), Merck KGaA (Germany), General Electric (U.S), Agilent Technologies, Inc. (U.S), Takara Bio, Inc. (Japan), Harvard Bioscience (U.S), and Sebia Group (France)
|
|
Market Opportunities
|
|
Electrophoresis Reagents Market Dynamics
Drivers
- Increasing funding in the research and development (R&D) activities
Activities related to genomics and proteomics are expected to contribute to the revenue growth of the electrophoresis reagents market. With an increasing emphasis on personalised medicine and new drug discovery, pharmaceutical companies are focusing on the development of drugs that act directly at the molecular level by utilising genomic studies.
- Rising incidence rate of infectious diseases
Cancer and genetic disorders are expected to increase research funding from the local governments from various countries and private funding from pharmaceutical and biotechnology companies for development of efficient biologics for the treatment of these diseases which is evidently expected to boost demand for electrophoresis reagents over the forecast period.
Opportunities
Increasing levels and prevalence of chronic diseases and increased awareness and technological developments in the market is expected to drive the market growth. Low operating and instrument costs, rising applications in the pharmaceutical and biotechnology industries, and the growing burden of cancer, infectious diseases, and genetic disorders are the major driving factors in the gel electrophoresis segment. To identify SARS-CoV-2, gel-electrophoresis and RT-PCR tests are increasingly being used. For example, a study report published in 2020 by Wischmann F-J et al. said that employing gel-electrophoresis in tandem with traditional PCR for test analysis is a possible way to making SARS-CoV-2 diagnoses available worldwide.
Restraints/Challenges
- Time-consuming operations and limited sample analysis
Electrophoresis is a technique that is commonly used in molecular biochemistry, microbiology, and biomedical research. It is a protein separation method that uses protein sizes to separate the mixture. It is a powerful analysis technique and the only way to separate proteins for western blot RNA studies. It is also a time-consuming, costly, and technically skilled technique that functions as a market constraint. Overuse of time and resources in the process is often a hindrance to market expansion..
This electrophoresis reagents market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the electrophoresis reagents market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Electrophoresis Reagents Market
Globally, the COVID-19 outbreak was an unprecedented public health crisis that impacted nearly every industry. The pandemic has had a favourable impact on market growth since the electrophoresis technology has been utilised to create effective COVID-19 medicines, as it is used to separate DNA, RNA, or protein molecules based on their size. According to the National Clinical Trials Registry, Elsan is conducting a clinical trial to assess serum inflammation profiles by protein electrophoresis on patients hospitalised for SARS-CoV-2 virus infection. Thus, increased R&D activities in generating effective medicines are predicted to drive up demand for electrophoresis reagents from 2022 to 2029.
Global Electrophoresis Reagents Market Scope
The electrophoresis reagents market is segmented on the basis of product, technique, application and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- Gels
- Agarose Gels
- Starch Gels
- Polyacrylamide Gels
- Dyes
- Ethidium Bromide (ETBR) Dyes
- Sybr Dyes
- Bromophenol Dyes
- Buffers
- Tris-Acetate-EDTA (TAE)
- Tris-Borate-EDTA (TBE)
- Others
Technique
Application
- Protein Analysis
- DNA and RNA Analysis
End-User
- Research Institutions
- Pharmaceutical and Biotechnology Companies
- Hospitals and Clinics
- Diagnostic Laboratories
- Others
Electrophoresis Reagents Market Regional Analysis/Insights
The electrophoresis reagents market is analysed and market size insights and trends are provided by country, product, technique, application and end-user as referenced above.
The countries covered in the electrophoresis reagents market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America is expected to hold a significant market share in global electrophoresis reagents due to an increase in the number of proteomic and genomic research projects in Canada and the United States along with the rise in drug discovery research and the increase in the utilization of advanced diagnostics technologies.
Asia-Pacific is expected to grow at the significant growth during the forecast period of 2022 to 2029 due to increasing proteomics and genomics research, as well as the growing investments by pharmaceutical and biotechnology companies.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The electrophoresis reagents market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for electrophoresis reagents market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the electrophoresis reagents market. The data is available for historic period 2010-2020.
Competitive Landscape and Electrophoresis Reagents Market Share Analysis
The electrophoresis reagents market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to electrophoresis reagents market.
Some of the major players operating in the electrophoresis reagents market are:
- BioCT (U.S)
- Promega Corporation (U.S)
- EUROCLONE S.p.A. (Italy)
- Helena Laboratories Corporation (U.S)
- Apacor Limited (U.S)
- Thermo Fisher Scientific Inc. (U.S.)
- Sigma-Aldrich Corporation (U.S.)
- Bio-Rad Laboratories, Inc. (U.S.)
- Lonza (Switzerland)
- QIAGEN (Netherlands)
- Merck KGaA (Germany)
- General Electric (US)
- Agilent Technologies, Inc. (US)
- Takara Bio, Inc. (Japan)
- Harvard Bioscience (US)
- Sebia Group (France)
SKU-